Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by an All-encompassing Program Led by a Diabetes Specialist Team (EMERALD)

NCT03497390 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT03497390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03497390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by an All-encompassing Program Led by a Diabetes Specialist Team (EMERALD)
Lead sponsor
Chinese University of Hong Kong
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2012
Completion date
February 28, 2017
Enrollment
207 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

health care delivery